Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos.
Metrifonate, a long-acting cholinesterase (ChE) inhibitor with very low toxicity in warm-blooded animals, inhibits rat brain and serum cholinesterase (ChE) in vitro through its hydrolytic degradation product, dichlorvos. This conclusion is based on the finding that metrifonate-induced ChE inhibition showed the same pH dependence as its reported dehydrochlorination to dichlorvos. The ChE inhibition induced by dichlorvos was not pH dependent. It was mediated by a competitive drug interaction with the catalytic site of the enzyme, which led to irreversible inhibition within several minutes of incubation. After this time, addition of further substrate to the inhibited enzyme was not able to promote drug dissociation and hence enzyme reactivation. Similar characteristics of inhibition, i.e. interaction with the substrate binding site and time-dependent switch to non-competitive inhibition were observed with the reference compound, physostigmine. However, the physostigmine-induced inhibition of ChE could be readily reversed by further substrate addition. Another reference compound, tetrahydroaminoacridine (THA), also induced a reversible inhibition of rat brain and serum cholinesterase, but with a mechanism of action different from that of both dichlorvos and physostigmine in that enzyme inhibition occurred rapidly upon drug addition at an allosteric site on the enzyme surface. It is suggested that the unique slow release plus the slow inhibition of ChE by dichlorvos is responsible for the lower toxicity of metrifonate compared to that of directly acting ChE inhibitors.
Hinz
V C
VC
Institute for Neurobiology, Troponwerke GmbH & Co. KG, Cologne, Koln, Germany.
Grewig
S
S
Schmidt
B H
BH
D000818:Animals; D001673:Biodegradation, Environmental; D001921:Brain / Q000201:enzymology*; D002800:Cholinesterase Inhibitors / Q000493:pharmacokinetics* / Q000494:pharmacology*; D002802:Cholinesterases / Q000097:blood / Q000378:metabolism; D004006:Dichlorvos / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008297:Male; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013619:Tacrine / Q000494:pharmacology; D014236:Trichlorfon / Q000493:pharmacokinetics* / Q000494:pharmacology*
D002800:Cholinesterase Inhibitors; D013619:Tacrine; D004006:Dichlorvos; D010830:Physostigmine; D014236:Trichlorfon; D002802:Cholinesterases